Thomas M Annesley

Cyclosporine for Plaque-Type Psoriasis

Charles N. Ellis, Mark S. Fradin, Joseph M. Messana et al. · New England Journal of Medicine · 1991 · 431 citations · Full text

Systemic complement activation, lung injury, and products of lipid peroxidation.

Peter A. Ward, Gerd O. Till, J. Robert Hatherill et al. · Journal of Clinical Investigation · 1985 · 233 citations · Full text

Acute Lung Injury, Inflammatory Lung Disease, Immunotoxicology +21

Effects of magnesium sulfate on cardiac conduction and refractoriness in humans

Lorenzo A. DiCarlo, Fred Morady, Michael de Buitleir et al. · Journal of the American College of Cardiology · 1986 · 157 citations

Cardiac Muscle, Heart Failure, Cardiovascular Disease +11

Levels of Cyclosporin in Epidermis of Treated Psoriasis Patients Differentially Inhibit Growth of Keratinocytes Cultured in Serum Free Versus Serum Containing Media

Gary J. Fisher, Brian J. Nickoloff, Thomas M Annesley et al. · Journal of Investigative Dermatology · 1988 · 116 citations

Inflammation, Immunology, Keratinocytes Cultured +5

The erythromycin breath test as a predictor of cyclosporine blood levels

Paul B. Watkins, Ted Hamilton, Thomas M Annesley et al. · Clinical Pharmacology & Therapeutics · 1990 · 99 citations · Full text